Key facts
- This page summarizes John D. Quisel's Form 4 filing for Disc Medicine, Inc. (IRON).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Feb 2025, 18:35.
John D. Quisel - 10 Feb 2025 Form 4 Insider Report for Disc Medicine, Inc. (IRON)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- IRON
- Reported as of
- 10 Feb 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 Feb 2025, 18:35:51 UTC
- Prior SEC filing
- 02 Jan 2025
- Next SEC filing
- 20 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Rahul Khara, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John D. Quisel filed Form 4 for Disc Medicine, Inc. (IRON) on 12 Feb 2025.
Change
- Previous filing in this sequence was filed on 02 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IRON
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +78,337
- Change %
- +95%
- Price
- $0.000000
- Shares after
- 160,402
- Date
- 10 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IRON
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +117,505
- Change %
- Price
- $0.000000
- Shares after
- 117,505
- Date
- 10 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 117,505
- Exercise price
- $54.71
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest annually in four 25% installments commencing on February 15, 2026, subject to the Reporting Person's continued service on each such vesting date.
Footnote F2
The shares underlying this option vest in 48 equal monthly installments commencing on March 10, 2025, subject to the Reporting Person's continuted service on each such vesting date.